Título:

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Autores:

Elamin H. Elbasha (Merck & Co., Inc., Merck Sharp & Dohme)
Jagpreet Chhatwal (U Pittsburgh)
Shannon A. Ferrante (Merck Sharp & Dohme)
Antoine C. El Khoury (Merck Sharp & Dohme)
Pedro A. Laires (MSD Portugal)

Revista:

Applied Health Economics And Health Policy

Ano:

2013

Volume:

11

Número:

1

Páginas:

65-78

Código JEL:

D61 - Allocative Efficiency; Cost?Benefit Analysis